A free patient app paired with a prescriber portal. Patients log dosages, symptoms, side effects, and adherence. Prescribers monitor in real time and adjust treatment. The same architecture Richard runs at truMED LLC. Today it's a useful tool. With Module 2 of the ops plan, it becomes the pharmacovigilance and adherence engine that keeps Oleo locked in with prescribers.
OleoCare today is a useful adherence + monitoring tool. Three operational moves transform it into a strategic asset:
Auto-generated weekly summaries for prescribers. Anomaly flags. Pre-appointment briefings. Pharmacovigilance auto-flag for HPRA yellow card. Prescriber retention compounds, regulatory reporting becomes automatic.
Anonymised, opt-in adherence + outcome data. Becomes the citable evidence base for MCAP effectiveness. Useful in regulatory submissions, conference presentations, and scientific publication.
Once a consultant is using OleoCare, the data history is sticky. New entrant suppliers post MCAP-expansion will struggle to displace Oleo because the patient-data continuity matters.
OleoCare handles special-category health data. DPIA mandatory. AI module 2 must be built under HIPAA-equivalent posture, with penetration testing pre-launch. Nothing goes near patient data without proper scaffolding.